Where we are now in PDAC care: Clinical insights, emerging biomarkers and evolving therapeutic strategies

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss how biomarker-driven insights and emerging therapies are shaping treatment decisions in PDAC. They cover early testing strategies, novel targeted and immunologic therapies, and evidence-based treatment sequencing across the disease continuum. The experts: Dr. Allyson Ocean - Weill Cornell Medicine, New York, NY, USA Prof. Thierry Conroy - Institut de Cancérologie de Lorraine, University of Lorraine Nancy, France Dr. Eileen O'Reilly - Memorial Sloan Kettering Cancer Center, New York NY, United States This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Revolution Medicines. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchONCOLOGY.com